191 related articles for article (PubMed ID: 15139978)
1. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.
Chetchotisakd P; Sungkanuparph S; Thinkhamrop B; Mootsikapun P; Boonyaprawit P
HIV Med; 2004 May; 5(3):140-3. PubMed ID: 15139978
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.
Chariyalertsak S; Supparatpinyo K; Sirisanthana T; Nelson KE
Clin Infect Dis; 2002 Jan; 34(2):277-84. PubMed ID: 11740718
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J
N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
6. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Barbaro G; Barbarini G; Di Lorenzo G
Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
[TBL] [Abstract][Full Text] [Related]
9. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
[TBL] [Abstract][Full Text] [Related]
10. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.
Pappas PG; Chetchotisakd P; Larsen RA; Manosuthi W; Morris MI; Anekthananon T; Sungkanuparph S; Supparatpinyo K; Nolen TL; Zimmer LO; Kendrick AS; Johnson P; Sobel JD; Filler SG
Clin Infect Dis; 2009 Jun; 48(12):1775-83. PubMed ID: 19441980
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Powderly WG; Finkelstein D; Feinberg J; Frame P; He W; van der Horst C; Koletar SL; Eyster ME; Carey J; Waskin H
N Engl J Med; 1995 Mar; 332(11):700-5. PubMed ID: 7854376
[TBL] [Abstract][Full Text] [Related]
13. Survival time of HIV-infected patients with cryptococcal meningitis.
Chottanapund S; Singhasivanon P; Kaewkungwal J; Chamroonswasdi K; Manosuthi W
J Med Assoc Thai; 2007 Oct; 90(10):2104-11. PubMed ID: 18041430
[TBL] [Abstract][Full Text] [Related]
14. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.
Schaars CF; Meintjes GA; Morroni C; Post FA; Maartens G
BMC Infect Dis; 2006 Jul; 6():118. PubMed ID: 16846523
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
16. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
[TBL] [Abstract][Full Text] [Related]
17. Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.
Pappas PG; Bustamante B; Ticona E; Hamill RJ; Johnson PC; Reboli A; Aberg J; Hasbun R; Hsu HH
J Infect Dis; 2004 Jun; 189(12):2185-91. PubMed ID: 15181565
[TBL] [Abstract][Full Text] [Related]
18. Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial.
Techapornroong M; Suankratay C
Scand J Infect Dis; 2007; 39(10):896-901. PubMed ID: 17852947
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study of AIDS-associated cryptomeningitis.
Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S
BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
